Literature DB >> 21847358

Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.

Vegard Tjomsland1, Anna Spångeus, Johanna Välilä, Per Sandström, Kurt Borch, Henrik Druid, Sture Falkmer, Ursula Falkmer, Davorka Messmer, Marie Larsson.   

Abstract

The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) is dynamic, with an extensive interaction between the stroma and tumor cells. The aim of this study was to delineate the cross talk between PDAC and cancer-associated fibroblasts (CAFs), with a focus on the mechanism creating the chronic inflammatory tumor milieu. We assessed the effects of the cross talk between PDAC and CAF cell lines on the creation and sustenance of the inflammatory tumor microenvironment in pancreatic cancer. The coculture of PDAC and CAF cell lines enhanced the levels of inflammatory factors including IL-1α, IL-6, CXCL8, VEGF-A, CCL20, and COX-2. CAFs were superior to tumor cells regarding the production of most inflammatory factors, and tumor cell-associated IL-1α was established as the initiator of the enhanced production of inflammatory factors through the binding of IL-1α to IL-1 receptor 1 (IL-1R1) expressed predominantly by CAFs. Furthermore, we found a correlation between IL-1α and CXCL8 expression levels in PDAC tissues and correlation between IL-1α expression and the clinical outcome of the patients. This confirmed an important role for the IL-1 signaling cascade in the creation and sustenance of a tumor favorable microenvironment. Neutralization of the IL-1α signaling efficiently diminished the cross talk-induced production of inflammatory factors. These data suggest that the cross talk between PDAC cells and the main stroma cell type, i.e. CAFs, is one essential factor in the formation of the inflammatory tumor environment, and we propose that neutralization of the IL-1α signaling might be a potential therapy for this cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847358      PMCID: PMC3156657          DOI: 10.1593/neo.11332

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  50 in total

Review 1.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Authors:  Daruka Mahadevan; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2007-04-03       Impact factor: 6.261

2.  COX-2 involvement in breast cancer metastasis to bone.

Authors:  B Singh; J A Berry; A Shoher; G D Ayers; C Wei; A Lucci
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

3.  IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.

Authors:  Ming-Tsan Lin; Been-Ren Lin; Cheng-Chi Chang; Chia-Yu Chu; Hsiang-Ju Su; Szu-Ta Chen; Yung-Ming Jeng; Min-Liang Kuo
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

4.  Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.

Authors:  Hiroyuki Matsubayashi; Jeffrey R Infante; Jordan Winter; Alison P Klein; Richard Schulick; Ralph Hruban; Kala Visvanathan; Michael Goggins
Journal:  Cancer Biol Ther       Date:  2007-07-09       Impact factor: 4.742

5.  The role of interleukin 1 in growth and metastasis of human cancer xenografts.

Authors:  Dina M Elaraj; David M Weinreich; Sheelu Varghese; Markus Puhlmann; Stephen M Hewitt; Nancy M Carroll; Elizabeth D Feldman; Ewa M Turner; H Richard Alexander
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 6.  Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?

Authors:  Ron N Apte; Elena Voronov
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

Review 7.  Pancreatic cancer-associated stroma production.

Authors:  Murray Korc
Journal:  Am J Surg       Date:  2007-10       Impact factor: 2.565

8.  Cancer cell-derived IL-1alpha induces IL-8 release in endothelial cells.

Authors:  Jung-Hyo Rhim; Sin-Ae Kim; Ji-Eun Lee; Dong-Jo Kim; Hong Keun Chung; Kum-Joo Shin; Junho Chung
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-11       Impact factor: 4.553

9.  CXC chemokines located in the 4q21 region are up-regulated in breast cancer.

Authors:  Ivan Bièche; Carine Chavey; Catherine Andrieu; Muriel Busson; Sophie Vacher; Ludovic Le Corre; Jean-Marc Guinebretière; Sandrine Burlinchon; Rosette Lidereau; Gwendal Lazennec
Journal:  Endocr Relat Cancer       Date:  2007-12       Impact factor: 5.678

10.  Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.

Authors:  Hirozumi Sawai; Yuji Okada; Hitoshi Funahashi; Yoichi Matsuo; Hiroki Takahashi; Hiromitsu Takeyama; Tadao Manabe
Journal:  BMC Cell Biol       Date:  2006-02-20       Impact factor: 4.241

View more
  49 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

Authors:  Sofia R Gameiro; Jorge A Caballero; James W Hodge
Journal:  Cancer Biother Radiopharm       Date:  2012-02-08       Impact factor: 3.099

3.  Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.

Authors:  Imran Siddiqui; Marco Erreni; Mohammad Azhar Kamal; Chiara Porta; Federica Marchesi; Samantha Pesce; Fabio Pasqualini; Silvia Schiarea; Chiara Chiabrando; Alberto Mantovani; Paola Allavena
Journal:  Oncoimmunology       Date:  2017-11-01       Impact factor: 8.110

4.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

5.  IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.

Authors:  Giulia Biffi; Tobiloba E Oni; Benjamin Spielman; Yuan Hao; Ela Elyada; Youngkyu Park; Jonathan Preall; David A Tuveson
Journal:  Cancer Discov       Date:  2018-10-26       Impact factor: 39.397

6.  Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.

Authors:  Yohei Mano; Sachiyo Yoshio; Hirotaka Shoji; Shimagaki Tomonari; Yoshihiko Aoki; Nobuyoshi Aoyanagi; Toru Okamoto; Yoshiharu Matsuura; Yosuke Osawa; Kiminori Kimura; Kyohei Yugawa; Huanlin Wang; Yoshinao Oda; Tomoharu Yoshizumi; Yoshihiko Maehara; Tatsuya Kanto
Journal:  J Gastroenterol       Date:  2019-04-02       Impact factor: 7.527

7.  Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.

Authors:  David S Hong; Filip Janku; Aung Naing; Gerald S Falchook; Sarina Piha-Paul; Jennifer J Wheler; Siqing Fu; Apostolia M Tsimberidou; Michael Stecher; Prasant Mohanty; John Simard; Razelle Kurzrock
Journal:  Invest New Drugs       Date:  2015-03-31       Impact factor: 3.850

8.  Cancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer.

Authors:  Qian Zhang; Chunwei Peng
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

9.  Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.

Authors:  A Siletz; E Kniazeva; J S Jeruss; L D Shea
Journal:  Cancer Microenviron       Date:  2012-10-23

10.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.